Advanced technology with superior ease of use provides advanced STEMI decision support tools and gender-differentiated criteria to speed heart disease diagnosis
Barcelona, Spain – Royal Philips Electronics (AEX: PHI, NYSE: PHG) is to unveil its latest advance in cardiography, the PageWriter TC50 cardiograph, at the European Society of Cardiology (ESC) Congress 2009. On show for the first time, the PageWriter TC50 offers an intuitive 1-2-3 operation and advanced clinical decision support.
The PageWriter TC50 aims to help clinicians meet demands and shift the focus to patients. Its ability to handle up to 16 leads provides a more complete view of the heart, and its anatomically designed patient interface module makes attaching lead wires quick and intuitive, contributing to timely triage.
As heart disease manifests itself in different patients in different ways, physicians always face the challenge to quickly and accurately diagnose heart attacks. For this reason, Philips has packed the PageWriter TC50 with a variety of tools to aid clinicians with this task, including those enabled by the innovative DXL 16-lead ECG Algorithm. The DXL Algorithm’s ST Maps provide a graphical representation of ST elevation in patients, a key measure in the diagnosis of ischemia. STEMI-CA can identify which coronary artery is blocked, aiding the clinician in planning the appropriate intervention. In addition, since heart disease in women often occurs in smaller vessels with less obstruction(1) and more subtle symptoms(2), the ECG analysis programme used by the PageWriterTC50 uses gender-differentiated criteria to help interpret cardiac symptoms in women, including the identification of acute global ischemia.
“We have developed this product as part of Philips’ ongoing efforts to simplify cardiac care now and in the future,” commented Joris van den Hurk, vice president of cardiology programs for Philips Healthcare. “The PageWriter TC50 and the DXL Algorithm help clinicians in their decision-making by presenting the right information with clarity at the right time. As one product in our innovative Discovery to Treatment portfolio, the PageWriter TC50 supports healthcare facilities in their goal of meeting the ESC’s guideline of less than two hours from first medical contact to treatment(3).”
The PageWriter TC50 is available globally. You can visit Philips at ESC 2009 at Barcelona, Spain in booth # K 499 – Zone 3 Exhibition area from August 29 – September 2.
1. Pepine CJ, Kerensky RA, Lambert CR et al. Some thoughts on the vasculopathy of women with ischemic heart disease. Journal of American College of Cardiology 2006;47;S30-S35.
2. McSweeney JC, Cody M, O’Sullivan P et al. Women’s early warning symptoms of acute myocardial infarction. Circulation 2003;108:2619-2623.
3. Van de Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. European Heart Journal 2008; 29: 2909–2945.